Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
Current status of gene therapy strategies to treat HIV/AIDSDavid S Strayer, Ramesh Akkina, Bruce A Bunnell, et al.
Journal of Medical Primatology|August 28, 2022
Long-term evolutionary adaptation of SIVcpz toward HIV-1 using a humanized mouse modelKimberly Schmitt, James Curlin, Leila Remling-Mulder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 21, 2012
Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridgeJiehua Zhou, C Preston Neff, Piotr Swiderski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2007
Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cellsJoseph Anderson, Ming-Jie Li, Brent Palmer, et al.
Antiviral Research|March 20, 2017
2016 International meeting of the Global Virus NetworkRamesh Akkina, Heinz Ellerbrok, William Hall, et al.
Science Translational Medicine|January 21, 2011
An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized miceCharles Preston Neff, Jiehua Zhou, Leila Remling, et al.
Antiviral Research|November 8, 2019
2019 meeting of the global virus networkRamesh Akkina, Robert Garry, Christian Bréchot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2017
Safety and Efficacy of a Lentiviral Vector Containing Three Anti-HIV Genes-CCR5 Ribozyme, Tat-rev siRNA, and TAR Decoy-in SCID-hu Mouse-Derived T CellsJoseph Anderson, Ming-Jie Li, Brent Palmer, et al.
Virology|January 9, 2018
Zika viral infection and neutralizing human antibody response in a BLT humanized mouse modelKimberly Schmitt, Paige Charlins, Milena Veselinovic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2012
In vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4+ T cell levels in humanized miceBrent E Palmer, C Preston Neff, Jonathan Lecureux, et al.
Pageof 8